Report of Foreign Issuer (6-k)

Date : 09/14/2018 @ 12:23PM
Source : Edgar (US Regulatory)
Stock : Zealand Pharma A/S ADS (ZEAL)
Quote : 12.854  -1.016 (-7.33%) @ 1:33PM
Zealand Pharma A/S ADS share price Chart

Report of Foreign Issuer (6-k)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

September 14, 2018

 

Commission File Number: 001 - 38178

 

Zealand Pharma A/S

(Exact Name of Registrant as Specified in Its Charter)

 

Smedeland 36

2600 Glostrup (Copenhagen)

Denmark

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F     x            Form 40-F     o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):    o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):    o

 

Furnished as Exhibit 3.1 to this Report on Form 6-K are the Articles of Association of Zealand Pharma A/S, or the Company.

 

 

 



 

Warrant Exercise

 

On September 14, 2018, the Company has increased its share capital by a nominal amount of DKK 7,500 divided into 7,500 new shares with a nominal value of DKK 1 each. The increase is a consequence of the exercise of warrants granted under one of the Company’s employee warrant programs.

 

The exercise price was DKK 101.20 per share and the total proceeds to Zealand from the capital increase amount to DKK 759,000.00.

 

The new shares will be listed on Nasdaq Copenhagen after registration of the capital increase with the Danish Business Authority. Following registration of the new shares, the share capital of Zealand will be nominal DKK 30,758,827 divided into 30,758,827 shares with a nominal value of DKK 1 each.

 

The amendment to the Company’s Articles of Association resulting from the share capital increase has today been registered with the Danish Business Authority and is included as Exhibit 3.1 hereto and incorporated by reference herein

 

Exhibits

 

Reference is made to the Exhibit Index included hereto.

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

Zealand Pharma A/S

 

 

 

By:

/s/ Mats Blom

 

 

Name:

Mats Blom

 

 

Title:

Chief Financial Officer

 

Date: September 14, 2018

 

3



 

EXHIBIT INDEX

 

Exhibit
No.

 

Description

 

 

 

3.1

 

Articles of Association.

 

4


Zealand Pharma A/S ADS (NASDAQ:ZEAL)
Historical Stock Chart

1 Year : From Nov 2017 to Nov 2018

Click Here for more Zealand Pharma A/S ADS Charts.

Zealand Pharma A/S ADS (NASDAQ:ZEAL)
Intraday Stock Chart

Today : Monday 12 November 2018

Click Here for more Zealand Pharma A/S ADS Charts.

Latest ZEAL Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:us D:20181112 18:49:55